Market Overview:
The global eye drops grade cross-linked hyaluronic acid gel market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The high molecular weight SH segment is expected to dominate the market in terms of revenue share during the forecast period. The eye surgery application segment is projected to be the fastest-growing application segment during the forecast period. North America dominates the global eye drops grade cross-linked hyaluronic acid gel market, followed by Europe and Asia Pacific.
Product Definition:
Eye Drops Grade Cross-linked Hyaluronic Acid Gel is a transparent, colorless and viscous gel used as an ophthalmic lubricant and viscoelastic. It is also known as a tissue adhesive for lacerations of the eye.
High Molecular Weight SH:
High molecular weight hyaluronic acid (HMW-HA) is a form of cross-linked hyaluronic acid. It has been used in the treatment of ophthalmic conditions such as cataract, glaucoma, and age-related macular degeneration.
Low Molecular Weight SH:
Cross-linked hyaluronic acid is a high molecular weight polysaccharide that is naturally found in the human body. It has been used as an injectable drug for the treatment of dry eye disease since its approval by the U.S. FDA in 2009 and later on, it was approved for use as an intraocular lens (IOL) filler in 2010.
Application Insights:
The other application segment held the largest share of more than 70.0% in 2017. Other applications include ophthalmic medicines, corneal ulcers and others. The eye drops application segment is expected to witness significant growth over the forecast period owing to an increase in ocular allergies and dry eyes among other conditions that require frequent eye drops administration.
Dry eyes are a common problem especially among older people who often experience discomfort when they blink or close their eyes for a long time due to lack of sufficient tears production due to lower eyelid closure strength caused by shrinkage of the fat pad under the orbital rim ( inferior palpebral fold). This results in increased need for lubricants which can be supplied through eyewear prescription eyeglasses or non-prescription products such as tear gels, artificial tears etc.
Regional Analysis:
North America dominated the global eye drops grade cross-linked hyaluronic acid gel market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing per capita income, high level of healthcare awareness, and availability of advanced medical products in countries such as the U.S., Canada, and Mexico.
Asia Pacific is expected witness lucrative growth over the forecast period owing to factors such as growing economy coupled with improving healthcare infrastructure and rising disposable income resulting into increased demand for various advanced therapies including injectable drugs among patients suffering from eye diseases like macular degeneration (MD).
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 7.8% from 2016 to 2021. This is due to the benefits of these surgeries over traditional open surgery, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. The use of eye drops grade cross-linked hyaluronic acid gel in minimally invasive surgeries is expected to drive the growth of this market during the forecast period.
- Rising prevalence of age-related macular degeneration (AMD): AMD is a leading cause of vision loss in people aged 50 years and above. It affects the central part of the retina called the macula, which is responsible for clear vision needed for activities such as reading and driving. The number of people affected by AMD is estimated to reach 196 million by 2020, owing to increasing life expectancy and population growth rates worldwide. This will create a large pool of potential patients who can be treated with eye drops grade cross-linked hyaluronic acid gel products available in the market today or those that may be launched in future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Research Report
By Type
High Molecular Weight SH, Low Molecular Weight SH
By Application
Eye Surgery, Eye Drops, Other
By Companies
Stanford Chemicals, Contipro, Anika Therapeutics, Bloomage?Biotechnology, Haohai Biological, Hangzhou Singclean Medical Products, Zhejiang Jingjia Medical Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Report Segments:
The global Eye Drops Grade Cross-linked Hyaluronic Acid Gel market is segmented on the basis of:
Types
High Molecular Weight SH, Low Molecular Weight SH
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Eye Surgery, Eye Drops, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stanford Chemicals
- Contipro
- Anika Therapeutics
- Bloomage?Biotechnology
- Haohai Biological
- Hangzhou Singclean Medical Products
- Zhejiang Jingjia Medical Technology
Highlights of The Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- High Molecular Weight SH
- Low Molecular Weight SH
- By Application:
- Eye Surgery
- Eye Drops
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Eye Drops Grade Cross-linked Hyaluronic Acid Gel is a sterile, nonprescription eye drop that contains cross-linked hyaluronic acid. It is used to treat dry eyes and other conditions that cause inflammation and pain in the eyes.
Some of the key players operating in the eye drops grade cross-linked hyaluronic acid gel market are Stanford Chemicals, Contipro, Anika Therapeutics, Bloomage?Biotechnology, Haohai Biological, Hangzhou Singclean Medical Products, Zhejiang Jingjia Medical Technology.
The eye drops grade cross-linked hyaluronic acid gel market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size & Forecast, 2018-2028
4.5.1 Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size and Y-o-Y Growth
4.5.2 Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Absolute $ Opportunity
Chapter 5 Global Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Type
5.2.1 High Molecular Weight SH
5.2.2 Low Molecular Weight SH
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Applications
6.2.1 Eye Surgery
6.2.2 Eye Drops
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Eye Drops Grade Cross-linked Hyaluronic Acid Gel Analysis and Forecast
9.1 Introduction
9.2 North America Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Type
9.6.1 High Molecular Weight SH
9.6.2 Low Molecular Weight SH
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Applications
9.10.1 Eye Surgery
9.10.2 Eye Drops
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Eye Drops Grade Cross-linked Hyaluronic Acid Gel Analysis and Forecast
10.1 Introduction
10.2 Europe Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Type
10.6.1 High Molecular Weight SH
10.6.2 Low Molecular Weight SH
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Applications
10.10.1 Eye Surgery
10.10.2 Eye Drops
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Eye Drops Grade Cross-linked Hyaluronic Acid Gel Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Type
11.6.1 High Molecular Weight SH
11.6.2 Low Molecular Weight SH
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Applications
11.10.1 Eye Surgery
11.10.2 Eye Drops
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Eye Drops Grade Cross-linked Hyaluronic Acid Gel Analysis and Forecast
12.1 Introduction
12.2 Latin America Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Type
12.6.1 High Molecular Weight SH
12.6.2 Low Molecular Weight SH
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Applications
12.10.1 Eye Surgery
12.10.2 Eye Drops
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Eye Drops Grade Cross-linked Hyaluronic Acid Gel Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Type
13.6.1 High Molecular Weight SH
13.6.2 Low Molecular Weight SH
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market Size Forecast by Applications
13.10.1 Eye Surgery
13.10.2 Eye Drops
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market: Competitive Dashboard
14.2 Global Eye Drops Grade Cross-linked Hyaluronic Acid Gel Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Stanford Chemicals
14.3.2 Contipro
14.3.3 Anika Therapeutics
14.3.4 Bloomage?Biotechnology
14.3.5 Haohai Biological
14.3.6 Hangzhou Singclean Medical Products
14.3.7 Zhejiang Jingjia Medical Technology
